Freeman, MD J. FDA approves Alzheimer’s drug against the recommendation of its scientific panel. Be very concerned. rrnmf [Internet]. 2021 Dec. 20 [cited 2024 Nov. 27];2(5):5-6. Available from: https://journals.ku.edu/rrnmf/article/view/15979